These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11559212)

  • 41. The importance of anatomic site in prognosis in patients with cutaneous melanoma.
    Wong JH; Wanek L; Chang LJ; Goradia T; Morton DL
    Arch Surg; 1991 Apr; 126(4):486-9. PubMed ID: 2009064
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The long-term results and prognostic significance of cutaneous melanoma surgery using sentinel node biopsy with triple technique.
    Rutkowski P; Szydłowski K; Nowecki ZI; Sałamacha M; Goryń T; Mitręga-Korab B; Pieńkowski A; Dziewirski W; Zdzienicki M
    World J Surg Oncol; 2015 Oct; 13():299. PubMed ID: 26462471
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
    Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
    Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.
    Dadras SS; Paul T; Bertoncini J; Brown LF; Muzikansky A; Jackson DG; Ellwanger U; Garbe C; Mihm MC; Detmar M
    Am J Pathol; 2003 Jun; 162(6):1951-60. PubMed ID: 12759251
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A long-term analysis of 620 patients with malignant melanoma at a major referral center.
    Averbook BJ; Russo LJ; Mansour EG
    Surgery; 1998 Oct; 124(4):746-55; discussion 755-6. PubMed ID: 9780997
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mitotic rate and subcutaneous involvement are prognostic factors for survival after recurrence in patients with only locoregional skin metastasis as the first site of recurrence from cutaneous melanoma.
    Messeguer F; Agustí-Mejías A; Traves V; Requena C; Alegre V; Guillén C; Oliver V; Nagore E
    J Eur Acad Dermatol Venereol; 2013 Apr; 27(4):436-41. PubMed ID: 22303982
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic subclassifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark's level of invasion: results of a population-based study from the Swedish Melanoma Register.
    Lyth J; Hansson J; Ingvar C; Månsson-Brahme E; Naredi P; Stierner U; Wagenius G; Lindholm C;
    Br J Dermatol; 2013 Apr; 168(4):779-86. PubMed ID: 23066913
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 4. The relation of cross-sectional profile, level of invasion, ulceration and vascular invasion to tumour type and prognosis.
    Larsen TE; Grude TH
    Acta Pathol Microbiol Scand A; 1979 Mar; 87A(2):131-8. PubMed ID: 433595
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Value of DNA ploidy and S-phase fraction as prognostic factors in stage III cutaneous melanoma.
    Martin G; Halwani F; Shibata H; Meterissian S
    Can J Surg; 2000 Feb; 43(1):29-34. PubMed ID: 10714254
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sarcopenia as a prognostic factor among patients with stage III melanoma.
    Sabel MS; Lee J; Cai S; Englesbe MJ; Holcombe S; Wang S
    Ann Surg Oncol; 2011 Dec; 18(13):3579-85. PubMed ID: 21822551
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Primary cutaneous melanoma. Prognostic classification of anatomic location.
    Garbe C; Büttner P; Bertz J; Burg G; d'Hoedt B; Drepper H; Guggenmoos-Holzmann I; Lechner W; Lippold A; Orfanos CE
    Cancer; 1995 May; 75(10):2492-8. PubMed ID: 7736393
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma.
    Blaheta HJ; Ellwanger U; Schittek B; Sotlar K; MacZey E; Breuninger H; Thelen MH; Bueltmann B; Rassner G; Garbe C
    J Invest Dermatol; 2000 Apr; 114(4):637-42. PubMed ID: 10733666
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic impact of regression in patients with primary cutaneous melanoma >1 mm in thickness.
    Ribero S; Galli F; Osella-Abate S; Bertero L; Cattaneo L; Merelli B; Tondini C; Ghilardi L; De Giorgi V; Occelli M; Quaglino P; Cassoni P; Palmieri G; Massi D; Mandala M;
    J Am Acad Dermatol; 2019 Jan; 80(1):99-105.e5. PubMed ID: 30447951
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic significance of extent of ulceration in primary cutaneous melanoma.
    Grande Sarpa H; Reinke K; Shaikh L; Leong SP; Miller JR; Sagebiel RW; Kashani-Sabet M
    Am J Surg Pathol; 2006 Nov; 30(11):1396-400. PubMed ID: 17063079
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
    Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
    Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Thompson JF; Scolyer RA
    Ann Surg; 2012 Jan; 255(1):128-33. PubMed ID: 21975320
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is head and neck melanoma different from trunk and extremity melanomas with respect to sentinel lymph node status and clinical outcome?
    Fadaki N; Li R; Parrett B; Sanders G; Thummala S; Martineau L; Cardona-Huerta S; Miranda S; Cheng ST; Miller JR; Singer M; Cleaver JE; Kashani-Sabet M; Leong SP
    Ann Surg Oncol; 2013 Sep; 20(9):3089-97. PubMed ID: 23649930
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognosis of primary melanoma.
    Ilmonen S; Asko-Seljavaara S; Kariniemi AL; Jeskanen L; Pyrhönen S; Muhonen T
    Scand J Surg; 2002; 91(2):166-71. PubMed ID: 12164517
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Highly invasive melanoma cells activate the vascular endothelium via an MMP-2/integrin αvβ5-induced secretion of VEGF-A.
    Desch A; Strozyk EA; Bauer AT; Huck V; Niemeyer V; Wieland T; Schneider SW
    Am J Pathol; 2012 Aug; 181(2):693-705. PubMed ID: 22659470
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The vascularity of cutaneous melanoma: a quantitative histological study of lesions 0.85-1.25 mm in thickness.
    Carnochan P; Briggs JC; Westbury G; Davies AJ
    Br J Cancer; 1991 Jul; 64(1):102-7. PubMed ID: 1854608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.